SRx Health Solutions and NYSE Notification
TAMPA, Fla. — SRx Health Solutions, Inc. (NYSE American: SRXH), a prominent name in global health and wellness, has announced significant news regarding its compliance status with the NYSE American. The company received a notification from NYSE Regulation about not meeting the continued listing standards set by the Exchange, specifically under Section 1007 of the NYSE American Company Guide.
Details of the Compliance Issue
The notice was triggered by the company’s failure to submit its Quarterly Report on Form 10-Q for the quarter ending June 30. The expected due date for this important filing was August 19. This delay, referred to as the Filing Delinquency, puts the company under scrutiny, as NYSE American monitors its situation over the next six months.
The Initial Cure and Additional Cure Period
During this Initial Cure Period, NYSE American will stay in touch with SRx Health Solutions to keep track of the filing status. Should the company fail to resolve this issue within the specified timeframe, it might be granted an Additional Cure Period of up to six months, depending on the specific circumstances surrounding their case.
Company Efforts to Address the Issue
SRx Health Solutions has expressed its commitment to resolving this situation quickly. The company is actively collaborating with its auditors and advisors to ensure that the delinquent report is completed and submitted without further delays. They are hopeful of filing the report by the end of the cure period, ensuring compliance with NYSE standards.
Impact on Trading
It is crucial to note that this notification does not immediately influence the trading or listing of the company’s shares on the Exchange. SRx Health Solutions is focused on regaining compliance with listing standards and is optimistic about meeting all necessary requirements. While there are no assurances of compliance at this stage, the company’s confidence remains high.
About SRx Health Solutions, Inc.
SRx Health Solutions Inc. is a comprehensive health service provider in Canada specializing in the specialty healthcare sector. With a network that covers all ten Canadian provinces, it stands as a leading provider of tailored healthcare services. The company utilizes its extensive industry knowledge and technology to deliver high-quality, patient-focused solutions aimed at enhancing the health and wellness of Canadians.
Company and Investor Contacts
For those interested in more detailed information about SRx Health Solutions, you can reach out directly:
Company Contact:
SRx Health Solutions, Inc.
Kent Cunningham, Chief Executive Officer
Investor Contact:
KCSA Strategic Communications
Valter Pinto, Managing Director
T: 212-896-1254
Email: Valter@KCSA.com
Frequently Asked Questions
What is the recent announcement made by SRx Health Solutions?
SRx Health Solutions announced that it received a late filing notification from the NYSE American regarding its compliance status.
What caused the late filing notification?
The notification was due to the company’s failure to timely file its Quarterly Report on Form 10-Q for the quarter ending June 30.
What is the Initial Cure Period?
The Initial Cure Period is a six-month window during which NYSE monitors SRx Health Solutions to see if they can resolve the filing issue.
Will this notification affect the trading of the company’s stock?
No, the notification does not immediately affect the trading or listing of the company’s common stock.
How is SRx Health Solutions addressing the late filing issue?
The company is working diligently with its auditors to complete and submit the delayed report as swiftly as possible.
